Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer.
Emmanuel S AntonarakisNicole ZhangJayati SahaLiina NevalaitaTarja IkonenL Jill TsaiChris GarrattKarim FizaziPublished in: JCO precision oncology (2024)
amplification) and reduced OS. These findings inform the development of novel therapies designed to circumvent AR-mediated therapeutic resistance.